ENGLISH
|
HINDI
APPS
iPhone
|
iPad
|
BlackBerry
|
Android
Nokia
Windows
Network18
Quotes
Quotes
NAVs
News
Messages
People
Notices
Videos
All
FEEDBACK
Facebook
Follow @moneycontrolcom on Twitter
CNBC TV 18
moneycontrol
News
Markets
Mutual Funds
IPO
Commodities
Wealth
Portfolio
Messages
My TV
Tax
Fixed Income
Property
SME
CNBC-TV18
Home
Business
General News
Market Trends
Stocks
Fund News
Personal Finance
Corporate Strategy
Lifestyle
Politics
Legal
Master Your Money
Share
>
Share
Tweet
Share on Tumblr
Kwizda Pharma Gmbh
News »
latest
by relevance
Magna ties up with German co to launch 40 healthcare products
Sep 20, 2011 at 11:41 | Source:
PTI
Mumbai, Sep 19 (PTI) Pharma firm Magna Industries and Exports today entered into a tie-up with Germany's Sunlife, GmbH to launch a range of health care products in the country.
Cadila Healthcare buys German animal healthcare co
Jul 27, 2011 at 18:43 | Source:
Reuters
Indian drugmaker Cadila Healthcare said on Wednesday it has acquired Germany's Bremer Pharma GmBH for an undisclosed sum to expand its animal health business and gain access to key markets across Europe, South America, Asia and Africa.
Hoechst to buy UB group stake in Aventis Pharma
Mar 22, 2010 at 13:50 | Source:
Reuters
Aventis Pharma Ltd said on Monday its promoter Hoechst GmbH plans to raise its stake to 60.37% in the firm by acquiring 10.27% stake from the United Breweries group.
Lupin consolidated sales up 32% to Rs 9719 mn
Jan 29, 2009 at 15:00
Lupin consolidated sales up 32% to Rs 9719 mn, Net Profit - Rs 1165 mn. International market revenues at Rs. 6505 mn, recorded a rise of 48%. Of these, Formulation Business in Advanced Markets constituted 77% at Rs. 4990 mn.
Lupin cons Net Profit up 53% to Rs 1156 mn
Oct 24, 2008 at 12:07
Lupin Q2FY08-09 consolidated Net Profit up 53% to Rs 1156 Mn, Sales at Rs 9221 Mn up by 36%. International market revenues at Rs. 5449 mn, recorded a rise of 65%. Of these, Formulation Business in Advanced Markets constituted 70% at Rs. 3820 mn. Formulation revenues from domestic market at recorded an increase of 24% to Rs. 3033 mn.
Lupin acquires Hormosan Pharma GmbH
Jul 30, 2008 at 18:20
Lupin Limited announced that it has acquired Hormosan Pharma GmbH (Hormosan), a German Sales and Marketing generics company specialized in the supply of pharmaceutical products for the Central Nervous System (CNS).
Magna ties up with German co to launch 40 healthcare products
Sep 20, 2011 at 11:41 | Source:
PTI
Mumbai, Sep 19 (PTI) Pharma firm Magna Industries and Exports today entered into a tie-up with Germany's Sunlife, GmbH to launch a range of health care products in the country.
Cadila Healthcare buys German animal healthcare co
Jul 27, 2011 at 18:43 | Source:
Reuters
Indian drugmaker Cadila Healthcare said on Wednesday it has acquired Germany's Bremer Pharma GmBH for an undisclosed sum to expand its animal health business and gain access to key markets across Europe, South America, Asia and Africa.
Hoechst to buy UB group stake in Aventis Pharma
Mar 22, 2010 at 13:50 | Source:
Reuters
Aventis Pharma Ltd said on Monday its promoter Hoechst GmbH plans to raise its stake to 60.37% in the firm by acquiring 10.27% stake from the United Breweries group.
Lupin consolidated sales up 32% to Rs 9719 mn
Jan 29, 2009 at 15:00
Lupin consolidated sales up 32% to Rs 9719 mn, Net Profit - Rs 1165 mn. International market revenues at Rs. 6505 mn, recorded a rise of 48%. Of these, Formulation Business in Advanced Markets constituted 77% at Rs. 4990 mn.
Lupin cons Net Profit up 53% to Rs 1156 mn
Oct 24, 2008 at 12:07
Lupin Q2FY08-09 consolidated Net Profit up 53% to Rs 1156 Mn, Sales at Rs 9221 Mn up by 36%. International market revenues at Rs. 5449 mn, recorded a rise of 65%. Of these, Formulation Business in Advanced Markets constituted 70% at Rs. 3820 mn. Formulation revenues from domestic market at recorded an increase of 24% to Rs. 3033 mn.
Lupin acquires Hormosan Pharma GmbH
Jul 30, 2008 at 18:20
Lupin Limited announced that it has acquired Hormosan Pharma GmbH (Hormosan), a German Sales and Marketing generics company specialized in the supply of pharmaceutical products for the Central Nervous System (CNS).
Photos »
/
Follow moneycontrol.com
Facebook
Twitter
Google Plus
RSS
Wap SMS
SMS
Alert
iPad
iPhone
Blackberry
OVI
Android
Window